10-Q: Surgery Partners Reports Q1 2024 Results: Revenue Growth and Strategic Acquisitions Drive Performance

Surgery Partners saw a 7.7% increase in revenue in the first quarter of 2024, driven by same-facility growth and strategic acquisitions.

Summary

• Surgery Partners reported a 7.7% increase in total revenue for the first quarter of 2024, reaching $717.4 million, compared to $666.2 million in the same period of 2023.
• The revenue growth was attributed to a 10.2% increase in days adjusted same-facility revenues, which included an 8.8% increase in revenue per case and a 1.3% increase in same-facility cases.
• Adjusted EBITDA for the quarter increased by 8.2% to $97.5 million, up from $90.1 million in the first quarter of 2023.
• The company experienced a net loss attributable to common stockholders of $12.4 million for the quarter, an improvement from a $24.9 million loss in the same period last year.
• Surgery Partners acquired controlling interests in two surgical facilities and several physician practices for $66.0 million in cash and $1.1 million in non-cash consideration.
• The company also sold a portion of its interest in a surgical facility for $1.5 million, resulting in deconsolidation of the facility.
• As of March 31, 2024, Surgery Partners owned or operated 165 surgical facilities, including 147 ASCs and 18 surgical hospitals across 33 states.

Sentiment

Score: 7

Explanation: The document shows positive trends in revenue and EBITDA growth, along with strategic acquisitions. However, the company still reported a net loss, which tempers the overall positive sentiment. The successful capital raise and improved financial performance suggest a positive outlook, but the risks and challenges in the healthcare sector warrant a cautious approach.

Positives

• The company experienced significant revenue growth, driven by both increased case volume and revenue per case.
• Adjusted EBITDA increased, indicating improved operational efficiency and profitability.
• The net loss attributable to common stockholders decreased, showing a positive trend in financial performance.
• Strategic acquisitions were completed, expanding the company's portfolio of facilities and physician practices.
• The company maintains a strong liquidity position with significant cash and borrowing capacity.

Negatives

• The company still reported a net loss attributable to common stockholders, although it was an improvement from the previous year.
• The company incurred $17.4 million in transaction and integration costs, which impacted profitability.
• The company experienced a net loss on disposals, consolidations and deconsolidations of $1.5 million.

Risks

• The company is subject to risks related to changes in payments from government health care programs and private insurance payors.
• The company faces competition for physicians, nurses, strategic relationships, acquisitions and managed care contracts.
• The company's ability to manage material liabilities incurred as a result of acquiring surgical facilities is a risk.
• The company is subject to the impact of future legislation and other health care regulatory reform actions.
• The company is exposed to the risk of cybersecurity attacks or intrusions.
• Broad economic factors, including recent increases in interest rates, inflation and supply chain risks and market volatility, could negatively affect the company's performance.

Future Outlook

The company believes that cash flows from operations, available cash, available capacity on its Revolver and continued anticipated access to capital markets, will be adequate to meet its short-term and long-term liquidity needs. The company continues to focus on improving same-facility performance, selectively acquiring established facilities, developing new facilities and other portfolio management initiatives.

Management Comments

• Management is focused on improving same-facility performance, selectively acquiring established facilities, developing new facilities and other portfolio management initiatives.
• Management believes the company's cash flows from operations, available cash, available capacity on its Revolver and continued anticipated access to capital markets, will be adequate to meet its short-term and long-term liquidity needs.

Industry Context

The healthcare industry is experiencing ongoing changes in reimbursement models and regulatory requirements. Surgery Partners' focus on multi-specialty surgical facilities and strategic acquisitions aligns with industry trends towards outpatient care and consolidation. The company's performance is influenced by factors such as payor mix, surgical case mix, and the ability to manage costs effectively.

Comparison to Industry Standards

• Surgery Partners' revenue growth of 7.7% is a positive sign, indicating the company is capturing market share and growing its business. This growth rate is comparable to other companies in the healthcare services sector, such as Tenet Healthcare and HCA Healthcare, which have also reported revenue growth in recent quarters.
• The company's Adjusted EBITDA growth of 8.2% is also a positive indicator of operational efficiency. This is in line with industry benchmarks for companies focused on outpatient surgical services.
• The net loss of $12.4 million, while an improvement, highlights the challenges in achieving profitability in the current healthcare environment. Other companies in the sector, such as Community Health Systems, have also reported losses, indicating the competitive and cost-intensive nature of the industry.
• Surgery Partners' strategic acquisitions are consistent with industry trends towards consolidation and expansion of service offerings. Companies like UnitedHealth Group and CVS Health have also been actively acquiring healthcare assets to expand their reach and capabilities.
• The company's focus on multi-specialty surgical facilities is a common strategy in the industry, as it allows for diversification of revenue streams and reduces reliance on any single procedure type. This is similar to the approach taken by companies like AmSurg and Envision Healthcare.

Stakeholder Impact

• Shareholders may view the improved financial performance and strategic acquisitions positively.
• Employees may benefit from the company's growth and expansion.
• Customers (patients) may experience improved access to healthcare services.
• Suppliers may see increased demand for their products and services.
• Creditors may be reassured by the company's strong liquidity position and successful capital raise.

Next Steps

• The company will continue to focus on improving same-facility performance.
• The company will continue to selectively acquire established facilities.
• The company will continue to develop new facilities.
• The company will continue to pursue other portfolio management initiatives.

Key Dates

Keywords

surgical facilities, ambulatory surgery centers, surgical hospitals, physician practices, healthcare, revenue growth, EBITDA, acquisitions, financial results, operating performance